|
|
Dr. Jakubowiak - A Multiple Myeloma Research Consortium (MMRC) Multicenter Phase I Trial of Perifosine (KRX-0401) in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM): Updated Results
Andrzej Jakubowiak, MD
University of Michigan Cancer Center
Ann Arbor, MI
|
|
|
01.08.08 |
To view the video full screen, click on the small
 button next to the volume control in the
lower right hand corner.
|
 related articles
|
|
back
print